Efficacy and Safety of Temozolomide-Based Regimens in Patients With Advanced Pancreatic Neuroendocrine Tumors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
BMC Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and safety of temozolomide-based regimens in advanced pancreatic neuroendocrine tumors: a systematic review and meta-analysis
BMC Cancer 2024 Feb 12;24(1)192, E Taherifard, M Bakhtiar, M Mahnoor, R Ahmed, L Cavalcante, J Zhang, A SaeedFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.